POINTS OF DIFFERENTIATION

6

3D Mammogram is more accurate, detecting serious cancers 44% earlier than 2D alone

100% OF BIRAD 0’S FOLLOWED UP WITHIN 48 HOURS

When a SimonMed radiologist notates an image as Birad O, a SimonMed Women’s Care Coordinator will immediately follow up with the referring physician office to request referrals for additional diagnostic imaging and or ultrasounds as needed. At SimonMed, it is our goal to have all additional testing scheduled within 2-3 days. .

BIRAD 4’S & 5’S

100% OF BIRAD 4 & 5’S FOLLOWED UP WITH 24 HOURS

When a SimonMed radiologist notates a mammogram image as Birad 4 or 5, the referring physician is contacted immediately. Standard treatment protocol in these cases is a tissue biopsy which can also be provided by SimonMed. Results of the biopsy are then forwarded to the referring physician who can put the patients mind at ease or handle the referral to a specialist as necessary.

POINTS OF DIFFERENTIATION

3D MAMMO

44% increase in invasive cancer detected with 3D Mammography 29% increase in the detection of all breast cancers 16% decrease in recall rate from screening mammography

Breast tomosynthesis is a breakthrough in screening mammography that provides a clearer, more accurate view compared to digital mammography alone. Research on breast tomosynthesis in large populations consistently show improved breast cancer detection rates, especially earlier invasive cancers, and a decrease in call backs by 16%, which may lessen anxiety for patients. Tomosynthesis produces a three-dimensional multi-slice view of the breast tissue that helps our fellowshiptrained breast radiologists identify and characterize individual breast structures without the issue of overlapping tissue. Several large clinical studies have shown that a 3D mammogram is more accurate, detecting serious cancers 44% earlier than 2D alone. 3D mammography is approved for all women who would be undergoing a standard mammogram regardless of age, breast type, screening/ diagnostic mammogram. .

7

A Breast Risk Assessment Test can determine if a woman is at low, average or high risk

BREAST DENSITY

40% of women have dense breast tissue

To improve our screening results, in February 2017, we decided to purchase iCad with Breast Density. This application scores the patient’s breast tissue and classifies them into 4 different categories of breast density:

A (Fatty Breast Tissue) B (Scattered Fibroglandular) C (Heterogeneously) D (Extremely Dense)

These classifications increase consistency, and give our radiologists more information on the patient and the tools to better assess patient needs.

ABVS

» Automated Breast Volume Scanner (ABVS) by Siemens Healthcare » Standalone system that also uses a high frequency, large-format transducer to acquire 3-D volumetric imaging of the breast » For dense breasts and can improve breast cancer detection by 55% over mammography » Supplemental screening options for women with dense breasts.

L I F E T I M E R I S K

A Breast Risk assessment test can determine if a woman is at low, average or high risk for breast cancer. Knowing their risk is a necessity on making screening recommendations for them. Typically, women who are at high risk have a strong family history of breast cancer. According to the American Cancer Society other risk factors include race and ethnicity, those with dense breast tissue, those who started menstruating prior to age 12, and lifestyle-related factors such as drinking alcohol and body mass index.